Mohamed Anwar ALI

Dr. Mohamed Anwar ALI


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 February 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
SASaleh Alghamdi
Saleh Alghamdi
IBIlhem Berrou
Ilhem Berrou
ZAZoe Aslanpour
Zoe Aslanpour
AMAlaa Mutlaq
Alaa Mutlaq
Abdul HaseebAbdul Haseeb
Abdul Haseeb
NSNada Shebl
Nada Shebl
Saudi hospitals and healthcare facilities are facing increasing rates of antimicrobial resistance and the emergence of new multi-drug resistant strains. This is placing an unprecedented threat to successful treatments and outcomes of patients accessing those facilities. The inappropriate use of antimicrobials is fueling this crisis, warranting urgent implementation of interventions to preserve antimicrobials and reduce resistance rates. Antimicrobial stewardship programmes (ASPs) can improve antimicrobial use, treatment success rates and reduce the levels of antimicrobial resistance. The Saudi Ministry of Health (MOH) devised a national antimicrobial stewardship plan to implement ASPs in hospitals, but little is known about the progress of implementation and the factors affecting it. This study aims to assess the level and the factors affecting the adoption and implementation of ASPs in Saudi hospitals at a national level. A nationwide cross-sectional survey was conducted in 2017 using an online questionnaire sent to all MOH hospitals. Overall, 147 out 247 MOH hospitals responded to the survey (54%). Only 26% of the hospitals reported the implementation of ASPs. Hospitals lack the knowledge, technological and staff resources to adopt and implement ASPs. Alternative models of ASP adoption could be explored to improve the rates of implementation of ASPs.

1 January 2019 in Journal of Research in Medical Sciences
Verified
Journal Article
Open access
PDF file
MAMohamed Anwar ALI
Mohamed Anwar ALI
SSSyed Azhar Syed Sulaiman
Syed Azhar Syed Sulaiman
NANor Azizah Aziz
Nor Azizah Aziz
DNDzul Azri Mohamed Noor
Dzul Azri Mohamed Noor
Background: Statins are recommended for cardiovascular protection for people with diabetes (high-risk groups). This study aimed to evaluate the gap between the guidelines of statin utilization and clinical practice among outpatients with type 2 diabetes regarding the patient's age and gender, to assess if this preventive drug is being satisfactorily utilized or not. Materials and Methods: In this cross-sectional study, patients aged 75 years, pregnant patients, and patients with type 1 diabetes, human immunodeficiency virus, or liver cirrhosis were excluded. Demographics, laboratory parameters, and prevalence of exposure to statin therapy were evaluated. This study was guided by the 2013 American College of Cardiology/American Heart Association cholesterol guidelines. IBM SPSS software was used for data management. Results: The study cohort involved 576 patients, with age being 58.3 ± 8.9 years. There were 50.5% of females and 49.5% of males. Overall 81.1% of patients aged 58.8 ± 8.8 years were statin users and 18.9% of patients aged 56.2 ± 9 years were statin nonusers. About 83.2% of females and 78.9% of males were prescribed statins. Statin medications included simvastatin 79.2%, atorvastatin 11.6%, lovastatin 5.8%, rosuvastatin 2.1%, and pravastatin 1.3%. Statin users’ and nonusers’ adherence was 56.5%, and 41.3% (P = 0.004), respectively. The adherence to medication plan of females and males was 55.7% and 51.6%, respectively (P = 0.004). Conclusion: Patients with diabetes who are at high risk of cardiovascular events, exposure to statin treatment is significantly less than perfect position both in females and males. Nearly one-fifth of the patients with type 2 diabetes are not using statins despite therapeutic necessities.

1 December 2020 in Clinical Epidemiology and Global Health
Verified
Journal Article
Open access
MAMahmoud Saeed Abdo
Mahmoud Saeed Abdo
MAMohamed Anwar ALI
Mohamed Anwar ALI
SHSabariah Noor Harun
Sabariah Noor Harun
TETajunisah Mohamed Eusoff
Tajunisah Mohamed Eusoff
SGSiti Maisharah Sheikh Ghadzi
Siti Maisharah Sheikh Ghadzi

9 March 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
SASaleh Alghamdi
Saleh Alghamdi
IBIlhem Berrou
Ilhem Berrou
EBEshtyag Bajnaid
Eshtyag Bajnaid
ZAZoe Aslanpour
Zoe Aslanpour
Abdul HaseebAbdul Haseeb
Abdul Haseeb
NSNada Shebl
Nada Shebl
Antimicrobial stewardship programs (ASPs) in hospitals have long been shown to improve antimicrobials’ use and reduce the rates of antimicrobial resistance. However, their implementation in hospitals, especially in developing countries such as Saudi Arabia, remains low. One of the main barriers to implementation is the lack of knowledge of how to implement them. This study aims to explore how an antimicrobial stewardship programme was implemented in a Saudi hospital, the challenges faced and how they were overcome, and the program outcomes. A key stakeholder case study design was used, involving in-depth semi-structured interviews with the core members of the ASP team and analysis of 35 ASP hospital documents. ASP implementation followed a top-down approach and involved an initial preparatory phase and an implementation phase, requiring substantial infectious diseases and clinical pharmacy input throughout. Top management support was key to the successful implementation. ASP implementation reduced rates of multi-drug resistance and prescription of broad-spectrum antimicrobials. The implementation of ASPs in hospital is administrator rather than clinician driven. Outsourcing expertise and resources may help hospitals address the initial implementation challenges.

1 July 2020 in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Verified
Journal Article
Closed access
MAMohamed Anwar ALI
Mohamed Anwar ALI
SSSyed Azhar Syed Sulaiman
Syed Azhar Syed Sulaiman
SASaleh Alghamdi
Saleh Alghamdi
AMAltaf Ali Mangi
Altaf Ali Mangi
NANor Azizah Aziz
Nor Azizah Aziz
DNDzul Azri Mohamed Noor
Dzul Azri Mohamed Noor

1 January 2017 in Journal of Pharmacy and Bioallied Sciences
Verified
Journal Article
Open access
MAMohamed Anwar ALI
Mohamed Anwar ALI
BTBalamurugan Tangiisuran
Balamurugan Tangiisuran
AKAbeerMohamed Kharshid
AbeerMohamed Kharshid
NANoorizan Abdul-Aziz
Noorizan Abdul-Aziz
YHYahaya Hassan
Yahaya Hassan
TETarekMohamed Elsayed
TarekMohamed Elsayed
E, mechanism, severity, with Type 2 diabetes. Settings and Design: A cross-sectional study was conducted in Penang General Hospital. Methods: A computerized system for DDI checking was used to assess the severity and mechanism of DDIs. Drug interaction probability scale was used to evaluate the likelihood of DDIs. Preventability of DDIs has been determined by the instrument of Hallas. The UCG prevalence related to DDIs was further assessed. Statistical Analysis Used: SPSS 21.00 was used in this study. Results: From 425 outpatients with HbA1c% test, their mean age was 58.7 ± 12.8 years. Only 225 (52.9%) cases had controlled glycemia while 200 (47.1%) cases with UCG. They had multiple comorbidities, with a mean number of 3.8 ± 2.2/patient and often prescribed with multiple medications, with a mean number of 6.33 ± 4.67/patient. It has been detected that 86 DDIs causing UCG in 46 patients (23%) with range of (1 – 4) DDIs per patient. Drugs with DDI-induced UCG were as follows: diuretics (79%), salbutamol (9.2%), cortisones (5.8%), and others (6%). The majority of these DDIs were categorized as possible (77.9%) and preventable (37%). Conclusion: Nearly one-quarter of UCG was induced by DDIs; most of these DDIs are possible, and more than one-third are preventable. It was concluded that thiazide diuretics have the highest prevalence of DDI-related UCG....